✦ LIBER ✦

A population study showing that the advent of second generation tyrosine kinase inhibitors has improved progression-free survival in chronic myeloid leukaemia

✍ Scribed by Francis, Sebastian; Lucas, Claire; Lane, Steven; Wang, Lihui; Watmough, Sarah; Knight, Katy; Bell, Jo; Kaleel-Rahman, Mohammed; Lee, Edwin; O’Brien, David; Butt, Nauman M.; Sadik, Walid; De Soysa, Lally; Seale, Jim R.C.; Salim, Rahuman; Clark, Richard E.

Book ID: 122834125
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 811 KB
Volume: 37
Category: Article
ISSN: 0145-2126
DOI: 10.1016/j.leukres.2013.04.003

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Restricted access to second generation t

Restricted access to second generation tyrosine kinase inhibitors in the UK could result in suboptimal treatment for almost half of chronic myeloid leukaemia patients: results from a West of Scotland and Lothian population study

✍ Paolo Gallipoli; Pat Shepherd; David Irvine; Mark Drummond; Tessa Holyoake 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB